These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25426282)

  • 1. Clinical transplantation and tolerance: are we there yet?
    Saidi RF; Hejazii Kenari SK
    Int J Organ Transplant Med; 2014; 5(4):137-45. PubMed ID: 25426282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.
    Feng S; Ekong UD; Lobritto SJ; Demetris AJ; Roberts JP; Rosenthal P; Alonso EM; Philogene MC; Ikle D; Poole KM; Bridges ND; Turka LA; Tchao NK
    JAMA; 2012 Jan; 307(3):283-93. PubMed ID: 22253395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finding the right time for weaning off immunosuppression in solid organ transplant recipients.
    Orlando G
    Expert Rev Clin Immunol; 2010 Nov; 6(6):879-92. PubMed ID: 20979553
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.
    Fairfield C; Penninga L; Powell J; Harrison EM; Wigmore SJ
    Cochrane Database Syst Rev; 2015 Dec; (12):CD007606. PubMed ID: 26666504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric transplantation and tolerance: past, present, and future.
    Kamran Hejazi Kenari S; Mirzakhani H; Saidi RF
    Pediatr Transplant; 2014 Aug; 18(5):435-45. PubMed ID: 24931282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization.
    Sarwal MM
    Clin Biochem; 2016 Mar; 49(4-5):404-10. PubMed ID: 26794635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operational tolerance: past lessons and future prospects.
    Levitsky J
    Liver Transpl; 2011 Mar; 17(3):222-32. PubMed ID: 21384504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of pediatric liver transplantation. Where are we coming from? Where do we stand?
    Otte JB
    Pediatr Transplant; 2002 Oct; 6(5):378-87. PubMed ID: 12390423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression in the pediatric transplant recipient.
    Blondet NM; Healey PJ; Hsu E
    Semin Pediatr Surg; 2017 Aug; 26(4):193-198. PubMed ID: 28964473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.
    Yao G; Albon E; Adi Y; Milford D; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2006 Dec; 10(49):iii-iv, ix-xi, 1-157. PubMed ID: 17134597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation. The pediatric challenge.
    McDiarmid SV
    Clin Liver Dis; 2000 Nov; 4(4):879-927. PubMed ID: 11232362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
    Shapiro R; Jordan ML; Basu A; Scantlebury V; Potdar S; Tan HP; Gray EA; Randhawa PS; Murase N; Zeevi A; Demetris AJ; Woodward J; Marcos A; Fung JJ; Starzl TE
    Ann Surg; 2003 Oct; 238(4):520-5; discussion 525-7. PubMed ID: 14530723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression: today, tomorrow, and withdrawal.
    Hirose R; Vincenti F
    Semin Liver Dis; 2006 Aug; 26(3):201-10. PubMed ID: 16850369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and prevention of post-transplant malignancies in kidney transplant recipients.
    Stallone G; Infante B; Grandaliano G
    Clin Kidney J; 2015 Oct; 8(5):637-44. PubMed ID: 26413294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune tolerance and immunosuppression in solid organ transplantation.
    Spearman CWN; Barday ZA
    S Afr Med J; 2014 Oct; 104(11):7307. PubMed ID: 29183441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.